• Why Vitrolife
    Your trusted partner Your IVF journey Being a Vitrolife customer Quality that matters Our company Career
  • IVF journey
  • Products
    Oocyte retrieval needles Sperm processing IVF media & oil Micromanipulation pipettes Labware Benchtop incubators Time-lapse systems & Evaluation tools Genomics Cryopreservation Laser & imaging systems Lab QC systems
  • Academy
  • Support
    Support Material Technical Support Clinical Support
  • Investors
    Läs sektionen på svenska
    The share Press releases Financial reports Financial calendar Corporate governance Sustainable business Business strategy Key figures Presentations Subscribe Contact
  • Blog
  • Log in
  • Contact us
  • Investors
  • Corporate governance
  • General meetings
  • Annual General Meeting of Vitrolife AB (publ) - 2006

Annual General Meeting of Vitrolife AB (publ) - 2006

At Vitrolife's Annual General Meeting on May 4, 2006 the following was among the decided:

  • No dividend will be paid for the financial year 2005.
  • Re-election of Board members Patrik Tigerschiöld, Per Båtelson and Madeleine Olsson-Eriksson and new election of Semmy Rülf, in accordance with the election committee's proposal.
  • Decision regarding changes in the Articles of Association due to the fact that a new Companies Act (2005:551) came into force on January 1, 2006 as well as changes of an editorial nature. The adopted changes were in accordance with the Board's proposal.
  • Authorization for the Board, for the time up until the next Annual General Meeting and on one or more occasions, to take a decision on the issue of a maximum of 2,100,000 shares in total, corresponding to approximately 9.6 percent of the company's share capital. The issue may deviate from the shareholders' pre-emptive rights through a non-cash issue, through offsetting or may otherwise be subscribed for in accordance with chapter 13 § 5, paragraph one, 6, of the Companies Act. The reason for the possible deviation from the shareholders' pre-emptive rights is to prepare the ground for a possible company acquisition.
  • Lars Hamberger was appointed honorary chairman for a period of two years.

At the Board meeting following election which was held after the Annual General Meeting, Patrik Tigerschiöld was elected Chairman of the Board.

Related files

  • Notice
  • P 13 Proposal new Articles of Association (Swe)
  • P 14 Proposal authorization for Board to issue shares (Swe)
  • Additional proposal Board

Career

  • Available positions
  • Working at Vitrolife

Webshop

  • Log in

Social media

Stay updated

We offer several opportunities to stay updated on the latest research, informative blog posts, upcoming events, product focus, events and much more.

Subscribe

All content © Vitrolife 2022. Products shown on this website might not be available on all markets.

  • Privacy policy
  • Legal notice
  • Cookie policy